December 15, 2011
New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver
|
November 23, 2011
First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe
|
November 22, 2011
BD Board Increases Dividend
|
November 22, 2011
BD to Present at the 23rd Annual Piper Jaffray Healthcare Conference
|
November 02, 2011
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year
|
October 28, 2011
BD Announces 2011 Analyst Day and Webcast
|
October 27, 2011
BD Introduces the World's First Safety-Engineered Pen Needle With Passive, Dual-Ended Protection
|
October 04, 2011
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 26, 2011
BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
|
September 21, 2011
BD Launches a New Generation Short Peripheral IV Catheter to Reduce Risk of Blood Exposure to Healthcare Workers
|
September 16, 2011
BD Celebrates 50 Years in Canaan, CT
|
September 13, 2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
|
September 07, 2011
BD to Present at the 2011 Morgan Stanley Global Healthcare Conference
|
August 24, 2011
BD Biosciences Announces Winners of Research Grant Program
|
August 18, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System
|
August 17, 2011
BD Manufacturing Facility in Broken Bow Achieves Company's Landfill-Free Status
|
August 16, 2011
BD Completes Acquisition of Carmel Pharma
|
August 15, 2011
BD Launches Family of Syringes Which Addresses Environmental Impact and Meets a Variety of Clinical Needs
|
August 03, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
|
August 02, 2011
BD Announces Results for 2011 Third Fiscal Quarter
|
July 27, 2011
BD Announces Agreement to Acquire Carmel Pharma, Inc.
|
July 26, 2011
BD Board Declares Dividend
|
July 26, 2011
BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011
|
July 12, 2011
BD Biosciences Announces Spring 2011 Winners of Research Grant Program
|
July 08, 2011
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
July 07, 2011
SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
|
July 06, 2011
BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
|
June 29, 2011
BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
|
June 20, 2011
Healthcare Workers Learn Improved Blood Collection Skills
|
June 09, 2011
Winning Photographers Bring Hope for a Healthy World
|
June 09, 2011
BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti
|
June 03, 2011
BD Celebrates Grand Opening of North American Professional Service Center in San Antonio, Texas
|
May 24, 2011
BD Board Declares Dividend
|
May 20, 2011
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow
|
May 19, 2011
BD Issues 2010 Sustainability Report
|
May 19, 2011
BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
|
May 09, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
|
May 06, 2011
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
|
May 03, 2011
Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
|
April 28, 2011
BD to Present at Investor Healthcare Conferences
|
April 26, 2011
BD Announces Results for 2011 Second Fiscal Quarter
|
April 15, 2011
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
April 14, 2011
BD Celebrates Expansion of Manufacturing Facility in Columbus, Nebraska
|
April 13, 2011
BD and Waste Management Launch Initiative to Recycle Medical Sharps
|
April 07, 2011
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue
|
April 05, 2011
BD Update Regarding Operations in Japan
|
April 04, 2011
New CDC Guidelines Recognize Value of Split Septum IV Access Technology to Reduce Intravascular Catheter-Related Bloodstream Infections
|
March 28, 2011
BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
|
March 21, 2011
World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings
|
March 18, 2011
BD Completes Acquisition of Accuri Cytometers, Inc.
|
March 15, 2011
BD Statement Regarding Impact of Japan Earthquake
|
March 15, 2011
BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts
|
February 16, 2011
BD Expands Industrial Microbiology Rapid Methods Portfolio
|
February 09, 2011
BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers
|
February 08, 2011
CEO Ed Ludwig Discusses Q1 FY11 Results on CNBC
|
February 07, 2011
BD Announces Results for 2011 First Fiscal Quarter
|
February 07, 2011
BD Announces Agreement to Acquire Accuri Cytometers, Inc.
|
February 01, 2011
BD Board Declares Dividend
|
February 01, 2011
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 24, 2011
BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal
|
January 05, 2011
BD Announces Webcast of Annual Meeting of Shareholders
|
January 04, 2011
BD to Present at the 29th Annual J. P. Morgan Healthcare Conference
|
January 03, 2011
New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients
|
